معرفی
Roles & Affiliations: Tongqing Li is an Associate Research Scientist in Pharmacology at Yale School of Medicine, part of Yale University. Their primary appointment is in the Department of Pharmacology. Li collaborates extensively with researchers like Daryl Klein and Sidi Chen, focusing on structural and molecular mechanisms in pharmacology and oncology.
Research Interests: Li’s work spans structural biology, cancer biology, and immunotherapy. Key areas include receptor-ligand interactions (e.g., ALK, GPCRs), CAR-T cell therapy for neuroblastoma, and antibody development against pathogens like SARS-CoV-2. Their studies often integrate structural analysis with functional pharmacology to understand disease mechanisms and therapeutic targets.
Publications: Recent work includes groundbreaking studies on the structural basis of receptor interactions and innovative approaches to CAR-T cell therapy. Li also contributed to the development of antibodies effective against viral variants, showcasing interdisciplinary collaboration.
Awards & Grants: While specific awards are not listed, Li’s publications reflect sustained research excellence and likely institutional support through grants. Collaborations with institutions like the Klein Lab highlight active grant-funded projects.
